• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过配体结合解析羟酸受体信号转导机制的结构基础。

Structural basis of hydroxycarboxylic acid receptor signaling mechanisms through ligand binding.

机构信息

TMDU Advanced Research Institute, Tokyo Medical and Dental University Bunkyo-ku, Tokyo, Japan.

Cellular and Structural Physiology Institute (CeSPI), Nagoya University, Nagoya, Japan.

出版信息

Nat Commun. 2023 Sep 22;14(1):5899. doi: 10.1038/s41467-023-41650-7.

DOI:10.1038/s41467-023-41650-7
PMID:37736747
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10516952/
Abstract

Hydroxycarboxylic acid receptors (HCA) are expressed in various tissues and immune cells. HCA2 and its agonist are thus important targets for treating inflammatory and metabolic disorders. Only limited information is available, however, on the active-state binding of HCAs with agonists. Here, we present cryo-EM structures of human HCA2-Gi and HCA3-Gi signaling complexes binding with multiple compounds bound. Agonists were revealed to form a salt bridge with arginine, which is conserved in the HCA family, to activate these receptors. Extracellular regions of the receptors form a lid-like structure that covers the ligand-binding pocket. Although transmembrane (TM) 6 in HCAs undergoes dynamic conformational changes, ligands do not directly interact with amino acids in TM6, suggesting that indirect signaling induces a slight shift in TM6 to activate Gi proteins. Structural analyses of agonist-bound HCA2 and HCA3 together with mutagenesis and molecular dynamics simulation provide molecular insights into HCA ligand recognition and activation mechanisms.

摘要

羟羧酸受体 (HCA) 在各种组织和免疫细胞中表达。因此,HCA2 及其激动剂是治疗炎症和代谢紊乱的重要靶点。然而,关于 HCA 与激动剂的活性结合状态的信息有限。在这里,我们展示了与人 HCA2-Gi 和 HCA3-Gi 信号复合物结合的多个结合化合物的冷冻电镜结构。激动剂与精氨酸形成盐桥,精氨酸在 HCA 家族中保守,从而激活这些受体。受体的细胞外区域形成一个类似盖子的结构,覆盖配体结合口袋。尽管 HCA 中的跨膜 (TM) 6 经历动态构象变化,但配体不会直接与 TM6 中的氨基酸相互作用,这表明间接信号转导导致 TM6 发生微小位移以激活 Gi 蛋白。激动剂结合的 HCA2 和 HCA3 的结构分析以及突变和分子动力学模拟为 HCA 配体识别和激活机制提供了分子见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b49b/10516952/dfdae68f6149/41467_2023_41650_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b49b/10516952/56bdf6b3223f/41467_2023_41650_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b49b/10516952/f6bd336c7d77/41467_2023_41650_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b49b/10516952/eda04daa18d8/41467_2023_41650_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b49b/10516952/18649a298a42/41467_2023_41650_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b49b/10516952/f228f80837dd/41467_2023_41650_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b49b/10516952/dfdae68f6149/41467_2023_41650_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b49b/10516952/56bdf6b3223f/41467_2023_41650_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b49b/10516952/f6bd336c7d77/41467_2023_41650_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b49b/10516952/eda04daa18d8/41467_2023_41650_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b49b/10516952/18649a298a42/41467_2023_41650_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b49b/10516952/f228f80837dd/41467_2023_41650_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b49b/10516952/dfdae68f6149/41467_2023_41650_Fig6_HTML.jpg

相似文献

1
Structural basis of hydroxycarboxylic acid receptor signaling mechanisms through ligand binding.通过配体结合解析羟酸受体信号转导机制的结构基础。
Nat Commun. 2023 Sep 22;14(1):5899. doi: 10.1038/s41467-023-41650-7.
2
Structural insights into the human niacin receptor HCA2-G signalling complex.人类烟酸受体 HCA2-G 信号复合物的结构见解。
Nat Commun. 2023 Mar 27;14(1):1692. doi: 10.1038/s41467-023-37177-6.
3
Structural basis for ligand recognition and signaling of hydroxy-carboxylic acid receptor 2.羟基羧酸受体 2 的配体识别和信号转导的结构基础。
Nat Commun. 2023 Nov 6;14(1):7150. doi: 10.1038/s41467-023-42764-8.
4
Hydroxycarboxylic Acid Receptor Ligands Modulate Proinflammatory Cytokine Expression in Human Macrophages and Adipocytes without Affecting Adipose Differentiation.羟基羧酸受体配体可调节人巨噬细胞和脂肪细胞中促炎细胞因子的表达,而不影响脂肪分化。
Biol Pharm Bull. 2018;41(10):1574-1580. doi: 10.1248/bpb.b18-00301.
5
The role of the C-terminus of the human hydroxycarboxylic acid receptors 2 and 3 in G protein activation using Gα-engineered yeast cells.利用Gα工程酵母细胞研究人类羟基羧酸受体2和3的C末端在G蛋白激活中的作用。
Eur J Pharmacol. 2016 Jan 5;770:70-7. doi: 10.1016/j.ejphar.2015.11.052. Epub 2015 Dec 4.
6
Natural biased signaling of hydroxycarboxylic acid receptor 3 and G protein-coupled receptor 84.羟基羧酸受体 3 和 G 蛋白偶联受体 84 的自然偏向信号传导。
Cell Commun Signal. 2020 Feb 26;18(1):31. doi: 10.1186/s12964-020-0516-2.
7
Structural insights into ligand recognition and activation of the succinate receptor SUCNR1.解析 SUCNR1 受体质子识别和激活的结构基础。
Cell Rep. 2024 Jul 23;43(7):114381. doi: 10.1016/j.celrep.2024.114381. Epub 2024 Jun 24.
8
Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor.胰高血糖素样肽-1受体跨膜结构域中参与配体结合和受体激活的残基:构建配体结合受体模型
Mol Endocrinol. 2011 Oct;25(10):1804-18. doi: 10.1210/me.2011-1160. Epub 2011 Aug 25.
9
Molecular recognition of niacin and lipid-lowering drugs by the human hydroxycarboxylic acid receptor 2.人源羟羧酸受体 2 对烟酸和降脂药物的分子识别。
Cell Rep. 2023 Nov 28;42(11):113406. doi: 10.1016/j.celrep.2023.113406. Epub 2023 Nov 11.
10
Activation and signaling mechanism revealed by GPR119-G complex structures.GPR119-G 复合物结构揭示的激活和信号转导机制。
Nat Commun. 2022 Nov 17;13(1):7033. doi: 10.1038/s41467-022-34696-6.

引用本文的文献

1
Cryo-EM ligand building using AlphaFold3-like model and molecular dynamics.使用类似AlphaFold3的模型和分子动力学进行冷冻电镜配体构建。
PLoS Comput Biol. 2025 Aug 11;21(8):e1013367. doi: 10.1371/journal.pcbi.1013367. eCollection 2025 Aug.
2
A large-scale curated and filterable dataset for cryo-EM foundation model pre-training.用于冷冻电镜基础模型预训练的大规模可策划且可过滤的数据集。
Sci Data. 2025 Jun 7;12(1):960. doi: 10.1038/s41597-025-05179-2.
3
Structural insights into ligand recognition and activation of human purinergic receptor P2Y14.

本文引用的文献

1
Insights into divalent cation regulation and G-coupling of orphan receptor GPR35.对孤儿受体GPR35的二价阳离子调节和G偶联的见解。
Cell Discov. 2022 Dec 21;8(1):135. doi: 10.1038/s41421-022-00499-8.
2
Emerging roles of GPR109A in regulation of neuroinflammation in neurological diseases and pain.GPR109A在神经疾病和疼痛的神经炎症调节中的新作用。
Neural Regen Res. 2023 Apr;18(4):763-768. doi: 10.4103/1673-5374.354514.
3
Molecular basis for the selective G protein signaling of somatostatin receptors.生长抑素受体选择性G蛋白信号传导的分子基础。
人类嘌呤能受体P2Y14配体识别与激活的结构洞察
Cell Discov. 2025 May 13;11(1):48. doi: 10.1038/s41421-025-00799-9.
4
Structures of G-protein coupled receptor HCAR1 in complex with Gi1 protein reveal the mechanistic basis for ligand recognition and agonist selectivity.与Gi1蛋白结合的G蛋白偶联受体HCAR1的结构揭示了配体识别和激动剂选择性的机制基础。
PLoS Biol. 2025 Apr 15;23(4):e3003126. doi: 10.1371/journal.pbio.3003126. eCollection 2025 Apr.
5
The structural basis of the G protein-coupled receptor and ion channel axis.G蛋白偶联受体与离子通道轴的结构基础。
Curr Res Struct Biol. 2025 Feb 18;9:100165. doi: 10.1016/j.crstbi.2025.100165. eCollection 2025 Jun.
6
Aromatic Amino Acid Metabolites: Molecular Messengers Bridging Immune-Microbiota Communication.芳香族氨基酸代谢产物:连接免疫-微生物群通讯的分子信使
Immune Netw. 2025 Feb 14;25(1):e10. doi: 10.4110/in.2025.25.e10. eCollection 2025 Feb.
7
Insights into the Activation Mechanism of HCA1, HCA2, and HCA3.对HCA1、HCA2和HCA3激活机制的见解。
J Med Chem. 2025 Feb 27;68(4):4527-4539. doi: 10.1021/acs.jmedchem.4c02567. Epub 2025 Feb 12.
8
Multiple recent HCAR2 structures demonstrate a highly dynamic ligand binding and G protein activation mode.多个最近的 HCAR2 结构展示了一个高度动态的配体结合和 G 蛋白激活模式。
Nat Commun. 2024 Jun 25;15(1):5364. doi: 10.1038/s41467-024-49536-y.
9
Structure-guided engineering of biased-agonism in the human niacin receptor via single amino acid substitution.通过单氨基酸取代对人烟酸受体中偏向激动作用进行结构导向工程改造。
Nat Commun. 2024 Mar 2;15(1):1939. doi: 10.1038/s41467-024-46239-2.
Nat Chem Biol. 2023 Feb;19(2):133-140. doi: 10.1038/s41589-022-01130-3. Epub 2022 Sep 22.
4
Computational insights on molecular interactions of acifran with GPR109A and GPR109B.计算研究阿昔福兰与 GPR109A 和 GPR109B 的分子相互作用。
J Mol Model. 2022 Jul 28;28(8):237. doi: 10.1007/s00894-022-05233-5.
5
Agonist and antagonist TRUPATH assays for G protein-coupled receptors.激动剂和拮抗剂 TRUPATH 测定法用于测定 G 蛋白偶联受体。
STAR Protoc. 2022 Apr 1;3(2):101259. doi: 10.1016/j.xpro.2022.101259. eCollection 2022 Jun 17.
6
The niacin receptor HCAR2 modulates microglial response and limits disease progression in a mouse model of Alzheimer's disease.烟酸受体HCAR2调节小胶质细胞反应并限制阿尔茨海默病小鼠模型中的疾病进展。
Sci Transl Med. 2022 Mar 23;14(637):eabl7634. doi: 10.1126/scitranslmed.abl7634.
7
Structural and Energetic Insights Into the Interaction of Niacin With the GPR109A Receptor.烟酸与GPR109A受体相互作用的结构与能量学见解
Bioinform Biol Insights. 2021 Nov 27;15:11779322211056122. doi: 10.1177/11779322211056122. eCollection 2021.
8
Highly accurate protein structure prediction with AlphaFold.利用 AlphaFold 进行高精度蛋白质结构预测。
Nature. 2021 Aug;596(7873):583-589. doi: 10.1038/s41586-021-03819-2. Epub 2021 Jul 15.
9
The therapeutic potential of GLP-1 receptor biased agonism.GLP-1 受体偏倚激动剂的治疗潜力。
Br J Pharmacol. 2022 Feb;179(4):492-510. doi: 10.1111/bph.15497. Epub 2021 May 20.
10
The role of structural dynamics in GPCR-mediated signaling.结构动力学在 G 蛋白偶联受体介导的信号转导中的作用。
FEBS J. 2021 Apr;288(8):2461-2489. doi: 10.1111/febs.15841.